HIV in body fluids during primary HIV infection: Implications for pathogenesis, treatment and public health

AIDS

Volumn 15, Issue 7, 2001, Pages 837-845

  Pilcher, Christopher D ^a,b,c,d,e,f   Shugars, Diane C ^a,b,c,d,e,f   Fiscus, Susan A ^a,b,c,d,e,f   Miller, William C ^a,b,c,d,e,f   Menezes, Prema ^a,b,c,d,e,f   Giner, Julieta ^a,b,c,d,e,f   Dean, Beth ^a,b,c,d,e,f   Robertson, Kevin ^a,b,c,d,e,f   Hart, Clyde E ^a,b,c,d,e,f   Lennox, Jeffrey L ^a,b,c,d,e,f   Eron Jr, Joseph J ^a,b,c,d,e,f   Hicks, Charles B ^a,b,c,d,e,f  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c IL   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e EMORY UNIVERSITY   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Acute infection; Antiretroviral therapy; Neurological brain; Oral medicine; Semen; Sexual transmission; Viral load

Indexed keywords

DIDANOSINE; HYDROXYUREA; NEVIRAPINE; STAVUDINE; VIRUS RNA;

ARTICLE; BODY FLUID; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MALE; MONONUCLEAR CELL; PATHOGENESIS; PLASMA; PRIORITY JOURNAL; PUBLIC HEALTH; SALIVA; SEMINAL PLASMA; UTERINE CERVIX MUCUS; VIRUS LOAD; VIRUS REPLICATION; VIRUS SHEDDING;

ANTI-HIV AGENTS; BODY FLUIDS; COHORT STUDIES; HIV INFECTIONS; HIV-1; HUMANS; PUBLIC HEALTH; RNA, VIRAL; VIRUS REPLICATION;

EID: 0035805178     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200105040-00004     Document Type: Article

References (40)

1. Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: Implications for timing of antiretroviral therapy
2. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques
3. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells
4. Characteristics of primary infection of a European human immunodeficiency virus type 1 clade B isolate in chimpanzees
5. Prevalence of behaviors likely to cause early secondary HIV transmission during the acute infection period and immediately after learning of infection, in a cohort of men who have sex with men (MSM)
6. Antiretroviral therapy for HIV infection in 1998: Updated recommendations of the International AIDS Society-USA panel
7. Antiretroviral-drug concentrations in semen: Implications for sexual transmission of human immunodeficiency virus type 1
8. Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1 infected men
9. The entry of antiviral and antiretroviral drugs into the central nervous system
10. Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir
11. Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: Implications for transmission
12. Human immunodeficiency virus in semen arises from a genetically distinct virus reservoir
13. Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources
14. Antiretroviral resistance mutations in human immunodeficiency virus type I reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples
15. In vivo compartmentalization of human immunodeficiency virus: Evidence from the examination of pol sequences from autopsy tissues
16. Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir
17. Symptomatic primary infection due to human immunodeficiency virus type 1; review of 31 cases
18. Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trial
19. Using PCR for detection of HIV-1 infection
20. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract
21. Performance of HIV RNA quantitation assays on HIV-negative specimens
22. Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments
23. CSF, plasma viral load and HIV associated dementia
24. Transient high levels of viremia in patients with primary humban immunodefieciecny virus type 1 infection
25. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection
26. Viral dynamics in primary HIV-1 infection
27. Biological and virologic characteristics of primary HIV infection
28. Latency and reservoirs for HIV-1
29. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure
30. Viral dynamics in primary HIV-1 infection
31. Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus
32. The role of early HIV infection in the spread of HIV through populations
33. Increased seminal shedding of HIV during primary infection augments the need for earlier diagnosis and prevention
34. Sexual transmission of HIV: Infectiousness and prevention
35. Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1
36. Risk factors and clinical presentation of acute primary HIV infection in India
37. Role of co-receptors in HIV-1 infection of the CNS. Neuroscience of HIV Infection
38. Unique HIV type 1 V3 region sequences derived from six different regions of brain: Regions-specific evolution within host-determined quasispecies
39. HIV-1 intrapatient sequence diversity in the immunogenic V3 region
40. Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: Support for the hypothesis of local virus replication